SCHEMBL14327068

SCHEMBL14327068

CCOC(CN(C)CC(=O)NC)c1cc(-c2ccc3cn(Cc4ccccc4)nc3c2)c2c(N)ncnn12

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 18/20 0.37
▸ RET P07949 1/20 0.34
▸ KDR P35968 1/20 0.34
▸ ACVRL1 P37023 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14327086 0.79 RIPK1 (0.36) RIPK1RETKDR
SCHEMBL14312813 0.78 ACVRL1 (0.43) RIPK1RETKDRACVRL1
SCHEMBL14327061 0.76 ACVRL1 (0.36) RIPK1RETKDRACVRL1
SCHEMBL14899104 0.74 ACVRL1 (0.40) RIPK1ACVRL1
SCHEMBL14327071 0.73 TYRO3 (0.44) RIPK1ACVRL1
SCHEMBL14312500 0.73 RIPK1 (0.41) RIPK1ACVRL1
SCHEMBL14531789 0.73 CFTR (0.34) RIPK1ACVRL1
SCHEMBL16496878 0.73 RIPK1 (0.43) RIPK1ACVRL1
SCHEMBL14313357 0.73 ACVRL1 (0.41) RIPK1ACVRL1
SCHEMBL5077843 0.73 ADORA3 (0.38) RIPK1ACVRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1945222-B1 PYRROLO[2,1-F] [1,2,4]-TRIAZIN-4-YLAMINES AS IGF-1R KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER HYPERPROLIFERATIVE DISEASES Bayer Pharma AG (DE) 2012-12-26 — — EP disclosed
Send feedback